Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?

Published:2021-06-22 Issue:10 Volume:23 Page:2199-2206
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Nakamura Akinobu¹^ORCID,Omori Kazuno¹,Terauchi Yasuo²

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

2. Department of Endocrinology and Metabolism, Graduate School of Medicine Yokohama City University Yokohama Japan

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14459

Reference81 articles.

1. The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy

2. The Central Role of Glucokinase in Glucose Homeostasis: A Perspective 50 Years After Demonstrating the Presence of the Enzyme in Islets of Langerhans

3. Present status of clinical deployment of glucokinase activators

4. Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase

5. Effects of Increased Glucokinase Gene Copy Number on Glucose Homeostasis and Hepatic Glucose Metabolism

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants;Biochemical Pharmacology;2024-11

2. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care;Biomedicines;2024-09-07

3. Unveiling the Genetic Basis and Metabolic Rewiring Behind the Galactose-Positive Phenotype in a Streptococcus thermophilus Mutant;Microbiological Research;2024-09

4. Compromised chronic efficacy of a Glucokinase Activator AZD1656 in mouse models for common humanGCKRvariants;2024-07-24

5. Targeting Protein Kinases to Protect Beta-Cell Function and Survival in Diabetes;International Journal of Molecular Sciences;2024-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3